Clinical Trial Update: The Effect of Gemcabene on Insulin Sensitivity in Nondiabetic Subjects [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the effect of gemcabene on insulin sensitivity in non-diabetic subjects has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insulin Resistance
• Insulin Sensitivity

Drugs mentioned

• gemcabene (gemcabene)

Snippet

Sponsor: NeuroBo Pharmaceuticals Inc. | Conditions: Insulin Sensitivity | Phase 2 | Status: COMPLETED